FRED B. DAVENPORT JR - 30 Oct 2025 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
Director
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Fred B. Davenport, Jr.
Issuer symbol
MEDP
Transactions as of
30 Oct 2025
Net transactions value
-$3,119,092
Form type
4
Filing time
03 Nov 2025, 16:46:36 UTC
Previous filing
20 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DAVENPORT FRED B JR Director C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI /s/ Stephen P. Ewald, Attorney-in-Fact for Fred B. Davenport, Jr. 03 Nov 2025 0001181154

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Options Exercise $355,895 +6,472 +216% $54.99 9,470 30 Oct 2025 Direct
transaction MEDP Common Stock Sale $3,474,987 -5,972 -63% $581.88 3,498 30 Oct 2025 Direct F1
holding MEDP Common Stock 2,000 30 Oct 2025 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEDP Stock Option (Right to Buy) Options Exercise $0 -6,472 -100% $0.000000 0 30 Oct 2025 Common Stock 6,472 $54.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $580.53 to $585.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F2 Owned by trust for the benefit of the Reporting Person.
F3 The option vested in full on May 14, 2020.